China De Xiao Quan Care Group Past Earnings Performance
Past criteria checks 2/6
There is insufficient data on China De Xiao Quan Care Group's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Tobacco Industry Growth | 18.1% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How China De Xiao Quan Care Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 23 | 0 | 2 | 0 | 0 |
31 Mar 23 | 0 | 1 | 0 | 0 |
31 Dec 22 | 0 | 1 | 0 | 0 |
30 Sep 22 | 0 | 0 | 0 | 0 |
30 Jun 22 | 0 | 0 | 0 | 0 |
31 Mar 22 | 0 | 0 | 0 | 0 |
31 Dec 21 | 0 | 0 | 0 | 0 |
30 Sep 21 | 0 | 0 | 0 | 0 |
30 Jun 21 | 0 | 0 | 0 | 0 |
31 Mar 21 | 0 | 0 | 0 | 0 |
31 Dec 20 | 0 | 0 | 0 | 0 |
31 Dec 19 | 0 | 0 | 0 | 0 |
30 Nov 16 | 0 | 0 | 0 | 0 |
31 Aug 16 | 0 | 0 | 0 | 0 |
31 May 16 | 0 | 0 | 0 | 0 |
29 Feb 16 | 0 | 0 | 0 | 0 |
30 Nov 15 | 0 | 0 | 0 | 0 |
31 Aug 15 | 0 | -1 | 1 | 0 |
31 May 15 | 0 | -1 | 1 | 0 |
28 Feb 15 | 0 | -1 | 1 | 0 |
30 Nov 14 | 0 | 0 | 0 | 0 |
31 Aug 14 | 0 | 0 | 0 | 0 |
31 May 14 | 0 | 0 | 0 | 0 |
28 Feb 14 | 0 | 0 | 0 | 0 |
30 Nov 13 | 0 | 0 | 0 | 0 |
Quality Earnings: CDXQ has a large one-off gain of $2.4M impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: CDXQ became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CDXQ has become profitable over the past 5 years.
Accelerating Growth: CDXQ has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: CDXQ has become profitable in the last year, making it difficult to compare its past year earnings growth to the Tobacco industry (2.4%).
Return on Equity
High ROE: CDXQ's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.